A Case of Suspected Drug Interaction Between Topiramate and Co-administered Clarithromycin/Pranlukast
Journal Title: Journal of Pharmaceutics & Pharmacology - Year 2017, Vol 5, Issue 1
Abstract
Case description: A 4-year-old boy presented with tuberous sclerosis and symptomatic partial epilepsy of the upper right extremity. Topiramate was prescribed for the treatment of epilepsy, and seizure behavior was well controlled. However, the patient experienced a significantly increased seizure frequency immediately after the administration of clarithromycin and pranlukast treatment during topiramate treatment. Topiramate is metabolized by CYP3A4, which is inhibited by clarithromycin and pranlukast. Thus, pharmacokinetic interactions may have occurred. This is the first report of a possible drug interaction between topiramate, clarithromycin, and pranlukast.
Authors and Affiliations
Noriaki Hidaka
Potential Impact of Cyclodextrin-Containing Formulations in Toxicity Evaluation of Novel Compounds in Early Drug Discovery
Cyclodextrins (CDs) are widely used as enabling excipients to improve in vivo drug delivery. The ability of CDs to form inclusion complexes with drugs and thereby improving solubility and stability of drugs is well estab...
Instability of Cefpodoxime Proxetil Oral Suspension at Different Temperature Storage Conditions
The advantages of oral dosage form over other dosage forms are responsible for its popularity which includes its ease of administration, patient compliance and stability of the formulation. This study compared the stabil...
NMDA Receptor Antagonism by Phencyclidine Reduces NWASP and WAVE1 Protein Expression and Reduces Levels of Myelination Markers in the Prefrontal Cortex of Rats
N-methyl-D-aspartate (NMDA) receptor antagonism by perinatal phencyclidine (PCP) treatment leads to neuronal damage and causes long-term behavioural alterations in rodents. It is routinely used to model pathological proc...
Another Example of a Successful Use of Computational and Modeling Tools from the Theory of Dynamic Systems in Pharmacokinetic Modeling
The objective of the current more or less theoretical study was to provide another example of a successful use of computational and modeling tools from the theory of dynamic systems in pharmacokinetic modeling. The tools...
Mathematical Model of Pharmacokinetic Behavior of Orally Administered Prednisolone in Healthy Volunteers
The objective of the current study was to develop mathematical models that described the pharmacokinetic behavior of prednisolone in healthy subjects after the oral administration of prednisolone. The current study is a...